Literature DB >> 16908994

Voxel-based morphometry in tau-positive and tau-negative frontotemporal lobar degenerations.

Jennifer L Whitwell1, Jason D Warren, Keith A Josephs, Alison K Godbolt, Tamas Revesz, Nick C Fox, Martin N Rossor.   

Abstract

BACKGROUND: The identification of specific, diagnostically useful predictors of protein dysfunction in the frontotemporal lobar degenerations (FTLD) is a problem of great clinical and biological interest. Correlations between regional patterns of tissue loss and specific proteinopathies have not been established.
OBJECTIVE: Specific brain imaging correlates of protein tau dysfunction were sought using voxel-based morphometry in FTLD subgroups with and without tau pathology.
METHODS: Seventeen patients with pathologically or genetically confirmed diagnoses of FTLD who had undergone volumetric brain magnetic resonance imaging (MRI) were identified retrospectively and tau-positive (n = 9) and tau-negative (n = 8) subgroups were defined. MRI data were compared with healthy age- and sex-matched controls using voxel-based morphometry implemented in a statistical parametric mapping software package.
RESULTS: Compared with controls, tau-positive and tau-negative subgroups had extensive common areas of regional brain atrophy predominantly affecting the frontal and anterior temporal lobes. No specific brain imaging features were identified for either subgroup.
CONCLUSION: Patterns of frontotemporal atrophy do not predict the presence or absence of tau pathology; conversely, different immunohistochemical profiles are associated with similar patterns of regional vulnerability to neuronal loss in FTLD. Copyright 2004 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 16908994     DOI: 10.1159/000080990

Source DB:  PubMed          Journal:  Neurodegener Dis        ISSN: 1660-2854            Impact factor:   2.977


  13 in total

Review 1.  FTD spectrum: Neuroimaging across the FTD spectrum.

Authors:  Jennifer L Whitwell
Journal:  Prog Mol Biol Transl Sci       Date:  2019-06-18       Impact factor: 3.622

Review 2.  Neuroimaging in frontotemporal lobar degeneration--predicting molecular pathology.

Authors:  Jennifer L Whitwell; Keith A Josephs
Journal:  Nat Rev Neurol       Date:  2012-01-31       Impact factor: 42.937

Review 3.  Biomarkers in frontotemporal lobar degenerations--progress and challenges.

Authors:  William T Hu; John Q Trojanowski; Leslie M Shaw
Journal:  Prog Neurobiol       Date:  2011-04-30       Impact factor: 11.685

4.  Clinicopathologic differences among patients with behavioral variant frontotemporal dementia.

Authors:  Mario F Mendez; Aditi Joshi; Kanida Tassniyom; Edmond Teng; Jill S Shapira
Journal:  Neurology       Date:  2013-01-16       Impact factor: 9.910

5.  MRI correlates of protein deposition and disease severity in postmortem frontotemporal lobar degeneration.

Authors:  Jennifer L Whitwell; Clifford R Jack; Matthew L Senjem; Joseph E Parisi; Bradley F Boeve; David S Knopman; Dennis W Dickson; Ronald C Petersen; Keith A Josephs
Journal:  Neurodegener Dis       Date:  2009-03-19       Impact factor: 2.977

6.  Longitudinal decline in autopsy-defined frontotemporal lobar degeneration.

Authors:  M Grossman; S X Xie; D J Libon; X Wang; L Massimo; P Moore; L Vesely; R Berkowitz; A Chatterjee; H B Coslett; H I Hurtig; M S Forman; V M-Y Lee; J Q Trojanowski
Journal:  Neurology       Date:  2008-04-16       Impact factor: 9.910

7.  Atrophy patterns in histologic vs clinical groupings of frontotemporal lobar degeneration.

Authors:  J M S Pereira; G B Williams; J Acosta-Cabronero; G Pengas; M G Spillantini; J H Xuereb; J R Hodges; P J Nestor
Journal:  Neurology       Date:  2009-05-12       Impact factor: 9.910

8.  Patterns of MRI atrophy in tau positive and ubiquitin positive frontotemporal lobar degeneration.

Authors:  E J Kim; G D Rabinovici; W W Seeley; C Halabi; H Shu; M W Weiner; S J DeArmond; J Q Trojanowski; M L Gorno-Tempini; B L Miller; H J Rosen
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-07-05       Impact factor: 10.154

9.  Clinicopathologic correlation in PGRN mutations.

Authors:  S Davion; N Johnson; S Weintraub; M-M Mesulam; A Engberg; M Mishra; M Baker; J Adamson; M Hutton; R Rademakers; E H Bigio
Journal:  Neurology       Date:  2007-05-23       Impact factor: 9.910

10.  Rates of cerebral atrophy differ in different degenerative pathologies.

Authors:  Jennifer L Whitwell; Clifford R Jack; Joseph E Parisi; David S Knopman; Bradley F Boeve; Ronald C Petersen; Tanis J Ferman; Dennis W Dickson; Keith A Josephs
Journal:  Brain       Date:  2007-03-08       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.